Equifax stock has fallen 30.6% over the past year, yet the current valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while earnings-based multiples suggest the shares trade on the expensive side.

• Over the past 1 year, Equifax has declined 30.6%, which puts the recent share price under pressure even before considering what any valuation model implies.
• Planned expansion in Mexico through the agreed US$750m acquisition of Círculo de Crédito can support longer term revenue and data-scale expectations. At the same time, signs of worsening financial health for the U.S. middle class may weigh on how investors think about credit-cycle risk and the timing of future cash flows.
• With a value score of 3 out of 6, Equifax currently screens as a mixed picture rather than a clear bargain or a clearly expensive stock on the broad set of valuation checks.

The issue now is whether Equifax’s market price or its intrinsic value estimate offers the more reliable guide for investors thinking about the stock from here.

Does Equifax Look Undervalued on Cash Flow?

The Discounted Cash Flow (DCF) model values Equifax by projecting future free cash flows and discounting them back to today. On this view, Equifax generated last twelve month free cash flow of about $1.1b, with the model assuming growing cash flows over time and an intrinsic value estimate of around $348.82 per share.

That compares to the current share price at a discount of roughly 48.5%. This points to Equifax stock screening as materially undervalued on cash flows. Equifax’s planned $750m acquisition of Círculo de Crédito in Mexico is a key part of this story because it adds scale and new data sources. The model treats these factors as supporting those future cash flow projections, even as concerns about U.S. consumer health keep the share price under pressure.

On the DCF numbers alone, Equifax currently screens as undervalued relative to what its projected cash flows suggest.

Our Discounted Cash Flow (DCF) analysis suggests Equifax is undervalued by 48.5%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks.

Has Equifax Run Too Far on Earnings?

The P/E ratio works well for Equifax because earnings are a key focus for how the stock is discussed and compared with other Professional Services companies. Right now, Equifax trades on about 30.6x earnings, versus an industry average P/E of around 21.0x and a peer-group average of roughly 28.1x. This means you are paying a higher multiple than you would for many sector peers.

The model based fair P/E for Equifax, which blends factors like its size, margins and risk profile, comes out at about 27.3x. That is below the current 30.6x and implies the stock carries a premium to what this framework suggests would be a more neutral earnings multiple. For investors, this indicates that the market is already placing a relatively full value on Equifax’s earnings, even after the recent share price decline.

On the P/E test, Equifax stock currently screens as overvalued, with the market pricing in a richer earnings multiple than the model based fair level.

The Equifax Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Equifax aim to close the gap between the DCF upside and the rich P/E multiple by spelling out which paths for Equifax's revenue, margins and earnings would make the stock worth materially more or less than today's price. Rather than relying on a single multiple or model, each Narrative lays out the assumptions sitting behind its view of fair value so you can compare them with actual results as they are reported, and they sit within Simply Wall St's Community page.

If you have a number driven view on whether Equifax's planned US$750m acquisition of Círculo de Crédito and its data on more than 80m identities really supports the current valuation, share a Narrative in the Simply Wall St community and spell out the assumptions behind your case. It is a chance to add your voice, set out a clear thesis and then track how it holds up as Equifax reports new results and provides updates on the deal.

Do you think there's more to the story for Equifax? Head over to our Community to see what others are saying!

The Bottom Line

For Equifax, the Discounted Cash Flow (DCF) view points to meaningful intrinsic value upside, while the P/E based view flags the stock as overvalued relative to its earnings and peers. That split comes down to whether you put more weight on long term cash flow potential from assets like the Círculo de Crédito deal, or on what investors are currently willing to pay for each dollar of earnings. With broader valuation checks sitting in the middle, the key question from here is whether Equifax can grow into its current multiple without investors reassessing credit cycle risks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.